COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 245 filers reported holding NEKTAR THERAPEUTICS in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2023$69,604
+15197.6%
99,010
-50.8%
0.00%
-75.0%
Q4 2022$455
-99.9%
201,153
+17.8%
0.00%
-20.0%
Q3 2022$546,000
-15.3%
170,749
+0.6%
0.01%
-28.6%
Q2 2022$645,000
-24.8%
169,807
+6.7%
0.01%
-12.5%
Q1 2022$858,000
-54.5%
159,106
+14.1%
0.01%
-60.0%
Q4 2021$1,884,000
+72.7%
139,489
+129.7%
0.02%
+53.8%
Q3 2021$1,091,000
+4.7%
60,723
-0.0%
0.01%
+8.3%
Q2 2021$1,042,000
-14.3%
60,734
-0.1%
0.01%
-20.0%
Q1 2021$1,216,000
+19.4%
60,777
+1.5%
0.02%
+7.1%
Q4 2020$1,018,000
+7.0%
59,908
+4.5%
0.01%
-26.3%
Q3 2020$951,000
+9.1%
57,338
+52.3%
0.02%
+18.8%
Q2 2020$872,000
+18.0%
37,656
-9.0%
0.02%
-5.9%
Q1 2020$739,000
+10.3%
41,388
+33.4%
0.02%
+41.7%
Q4 2019$670,000
+226.8%
31,029
+176.3%
0.01%
+200.0%
Q3 2019$205,000
-43.7%
11,232
+9.8%
0.00%
-33.3%
Q2 2019$364,000
+6.4%
10,233
+0.5%
0.01%0.0%
Q1 2019$342,000
+10.3%
10,179
+7.8%
0.01%0.0%
Q4 2018$310,000
-64.1%
9,442
-33.3%
0.01%
-50.0%
Q3 2018$863,000
+4.7%
14,153
-16.1%
0.01%
+9.1%
Q2 2018$824,000
-46.1%
16,866
+17.1%
0.01%
-47.6%
Q1 2018$1,530,00014,4000.02%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2020
NameSharesValueWeighting ↓
Strong Tower Advisory Services 404,972$6,913,0004.02%
GREAT POINT PARTNERS LLC 504,691$9,064,0002.11%
Camber Capital Management LP 3,750,000$67,350,0002.07%
ACT CAPITAL MANAGEMENT, LLC 161,500$2,901,0001.50%
Rhenman & Partners Asset Management AB 950,000$17,062,0001.20%
MAVERICK CAPITAL LTD 5,838,426$104,858,0001.06%
Birchview Capital, LP 72,000$1,293,0000.88%
Bellevue Group AG 4,594,656$82,519,0000.84%
CM Management, LLC 50,000$898,0000.67%
Duquesne Family Office 1,000,000$17,960,0000.58%
View complete list of NEKTAR THERAPEUTICS shareholders